BNTX
BioNTech SE · Healthcare · Market cap $22.0B(Price slightly stale)
Insiders sold $84.2M net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Oct 9, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$89.8M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Oct 9, 2026
Sahin Ugur
BioNTech SE (BNTX) has 15 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Oct 9, 2026.
Inside the rolling window, 2 insiders at BioNTech SE reported no open-market purchases and 27 open-market sales totaling $89.8M. The most active filer is Chief Executive Officer Sahin Ugur with 26 filings. Insiders have net sold $89.8M over the trailing 6 months. The most recent open-market filing is a sale of 27,000 shares by Chief Executive Officer Sahin Ugur, dated Oct 8, 2026, worth $2.5M.
- Industry:Biotechnology
- CEO:Ugur Sahin
- Employees:7,807
- HQ:Mainz, RP, DE
- IPO:2019-10-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 27,000 | $2.5M | Oct 9 | -10.4% | SEC ↗ | |
| Chief Executive Officer | Sale | 36,209 | $3.5M | Oct 9 | -10.4% | SEC ↗ | |
| Chief Executive Officer | Sale | 24,000 | $2.3M | Oct 7 | -8.8% | SEC ↗ | |
| Chief Executive Officer | Sale | 72,000 | $7.0M | Oct 6 | -9.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 21,000 | $2.0M | Oct 6 | -9.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 17,000 | $1.7M | Oct 2 | -10.4% | SEC ↗ | |
| Chief Executive Officer | Sale | 17,000 | $1.6M | Oct 2 | -10.4% | SEC ↗ | |
| Chief Executive Officer | Sale | 34,000 | $3.3M | Sep 30 | -11.6% | SEC ↗ | |
| Chief Executive Officer | Sale | 32,000 | $3.1M | Sep 30 | -11.6% | SEC ↗ | |
| Chief Executive Officer | Sale | 27,000 | $2.7M | Sep 28 | -12.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 34,000 | $3.3M | Sep 28 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 30,000 | $3.0M | Sep 24 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 39,000 | $3.9M | Sep 24 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 33,000 | $3.2M | Sep 22 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 46,000 | $4.6M | Sep 22 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 34,000 | $3.4M | Sep 18 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 30,000 | $2.9M | Sep 18 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 34,000 | $3.3M | Sep 16 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 15,000 | $1.4M | Sep 16 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 45,000 | $4.4M | Sep 14 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 41,000 | $4.1M | Sep 14 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 20,500 | $2.0M | Sep 11 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 37,000 | $3.7M | Sep 9 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 36,000 | $3.5M | Sep 9 | — | SEC ↗ | |
Sahin UgurFirst filing | Chief Executive Officer | Sale | 45,000 | $4.6M | Sep 8 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading BNTX 9 all-time
- DRep. Val HoyleOther$1,001 - $15,0002025-08-07
- DRep. Josh S. GottheimerOther$1,001 - $15,0002024-09-03
- DRep. Josh S. GottheimerOther$1,001 - $15,0002024-08-30
- DRep. Josh S. GottheimerPurchase$1,001 - $15,0002024-04-15
- DRep. Josh S. GottheimerOther$1,001 - $15,0002024-03-14
- DRep. Josh S. GottheimerPurchase$1,001 - $15,0002023-12-05
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does BNTX have?
BioNTech SE (BNTX) has 15 SEC Form 4 filings (27 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Oct 9, 2026.
When was the most recent SEC Form 4 filing for BNTX?
The most recent Form 4 filing for BNTX on Tracefour is dated Oct 9, 2026.
Who is the most active insider at BNTX?
The most active SEC Form 4 filer at BNTX in the rolling window is Chief Executive Officer Sahin Ugur, with 26 filings.
What is the net insider flow at BNTX over the last 6 months?
Over the trailing 180 days, insiders at BNTX have net sold $89.8M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at BNTX in the current window?
Inside the rolling window, insiders at BNTX bought $0 and sold $89.8M based on SEC Form 4 filings.
Can I get alerts for BNTX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at BioNTech SE (BNTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
BioNTech SE is in the Healthcare sector.